Recent Articles By The Author
Sharp drops in Heron Therapeutics and Supernus Pharmaceuticals have presented opportunities to make lemonade out of lemons.
Use buy-write or covered call orders with just out-of-the-money calls to average down in core small-cap holdings when inevitable declines occur.
A handful of midstream energy companies and a travel giant have seen insiders purchase their shares in recent weeks.
The planned acquisition of The Medicines Company by Novartis spurs prospects of other deals in the drug business.
There are a few plays to consider in the energy arena, but it still looks like a place to be underweight going into 2020.
Like Karuna, Sage Therapeutics and Intra-Cellular Therapies also deal in treatments in the mental health arena.